James Norman Frame
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Oncology top 10%
- Lung Cancer Research Studies
Papers in
-
- Pharmacogenetics and Drug Metabolism 5
-
- Platelet Disorders and Treatments 1
- Co-authors
- Robin T. Zon (4 shared papers)Barbara Weiffenbach (3 shared papers)Neil E. Caporaso (3 shared papers)Donald T. Moir (3 shared papers)Dana S. Wollins (2 shared papers)Linda D. Bosserman (2 shared papers)John M. Sorensen (1 shared paper)Donald A. Vena (1 shared paper)
- Journals
- Blood (6 papers)Journal of Oncology Practice (4 papers)Journal of Clinical Oncology (3 papers)American Journal of Hematology (2 papers)Lung Cancer (2 papers)
- Partner nations
- United StatesUnited KingdomMexico
In The Last Decade
James Norman Frame
34 papers receiving 911 citations
Peers
Comparison fields: 5 of 43
- Pharmacology 102
- Oncology 133
- Pulmonary and Respiratory Medicine 189
- Internal Medicine 18
- Genetics 41
Countries citing papers authored by James Norman Frame
This map shows the geographic impact of James Norman Frame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Norman Frame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Norman Frame more than expected).
Fields of papers citing papers by James Norman Frame
This network shows the impact of papers produced by James Norman Frame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Norman Frame. The network helps show where James Norman Frame may publish in the future.
Co-authors
The 25 scholars most cited alongside James Norman Frame, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 189 | |
| 2 | 1996 | 99 | |
| 3 | 1994 | 86 | |
| 4 | 2016 | 73 | |
| 5 | 1998 | 71 | |
| 6 | 1989 | 46 | |
| 7 | 1997 | 42 | |
| 8 | 1996 | 40 | |
| 9 | 2017 | 35 | |
| 10 | 1994 | 33 | |
| 11 | 2010 | 31 | |
| 12 | 1993 | 29 | |
| 13 | 1994 | 25 | |
| 14 | Debrisoquine metabolism and lung cancer risk. | 1995 | 24 |
| 15 | 1992 | 21 | |
| 16 | 2011 | 19 | |
| 17 | 2010 | 17 | |
| 18 | 1993 | 16 | |
| 19 | 2005 | 15 | |
| 20 | 2003 | 14 |
About James Norman Frame
James Norman Frame is a scholar working on Pharmacology, Hematology, Oncology, Surgery and Public Health, Environmental and Occupational Health, having authored 36 papers that have together received 976 indexed citations. Recurring topics across this work include Heparin-Induced Thrombocytopenia and Thrombosis (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Clinical practice guidelines implementation (2 papers), Lung Cancer Research Studies (2 papers), Neutropenia and Cancer Infections (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), Infectious Disease Case Reports and Treatments (1 paper) and Platelet Disorders and Treatments (1 paper). The work is most often cited by research in Pharmacology (102 citations), Oncology (133 citations), Pulmonary and Respiratory Medicine (189 citations), Internal Medicine (18 citations) and Genetics (41 citations). James Norman Frame has collaborated with scholars based in United States, United Kingdom and Mexico. Frequent co-authors include Robin T. Zon, Barbara Weiffenbach, Neil E. Caporaso, Donald T. Moir, Dana S. Wollins, Linda D. Bosserman, John M. Sorensen, Donald A. Vena, Ray D. Page and Bruce D. Cheson. Their work appears in journals such as Blood, Journal of Oncology Practice, Journal of Clinical Oncology, American Journal of Hematology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.